The price of Cabaletta Bio Inc (NASDAQ: CABA) closed at $20.38 in the last session, down -9.30% from day before closing price of $22.47. In other words, the price has decreased by -$2.09 from its previous closing price. On the day, 1358983 shares were traded.
Ratios:
We take a closer look at CABA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 15.65 and its Current Ratio is at 15.65. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on February 05, 2024, initiated with a Buy rating and assigned the stock a target price of $36.
On November 29, 2023, William Blair started tracking the stock assigning a Outperform rating and target price of $38.
On October 24, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $40.Cantor Fitzgerald initiated its Overweight rating on October 24, 2023, with a $40 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 19 ’24 when Binder Gwendolyn sold 11,000 shares for $19.59 per share. The transaction valued at 215,439 led to the insider holds 20,000 shares of the business.
Binder Gwendolyn sold 11,000 shares of CABA for $240,789 on Dec 19 ’23. The insider now owns 20,000 shares after completing the transaction at $21.89 per share. On Nov 20 ’23, another insider, Binder Gwendolyn, who serves as the insider of the company, sold 11,000 shares for $17.82 each. As a result, the insider received 196,014 and left with 20,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CABA now has a Market Capitalization of 962.83M and an Enterprise Value of 802.71M.
Stock Price History:
Over the past 52 weeks, CABA has reached a high of $26.35, while it has fallen to a 52-week low of $5.88. The 50-Day Moving Average of the stock is 22.39, while the 200-Day Moving Average is calculated to be 16.52.
Shares Statistics:
According to the various share statistics, CABA traded on average about 970.16K shares per day over the past 3-months and 874.69k shares per day over the past 10 days. A total of 42.85M shares are outstanding, with a floating share count of 33.75M. Insiders hold about 21.23% of the company’s shares, while institutions hold 96.26% stake in the company. Shares short for CABA as of Feb 15, 2024 were 6.83M with a Short Ratio of 7.04, compared to 6.42M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 15.94% and a Short% of Float of 18.06%.
Earnings Estimates
The company has 10 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.39 for the current quarter, with a high estimate of -$0.33 and a low estimate of -$0.45, while EPS last year was -$0.52. The consensus estimate for the next quarter is -$0.44, with high estimates of -$0.35 and low estimates of -$0.57.
Analysts are recommending an EPS of between -$1.5 and -$1.77 for the fiscal current year, implying an average EPS of -$1.6. EPS for the following year is -$1.72, with 11 analysts recommending between -$1.12 and -$2.11.
